HEADER LIGASE 04-NOV-22 8F16 TITLE STRUCTURE OF THE STUB1 TPR DOMAIN IN COMPLEX WITH H203, AN ALL-D TITLE 2 HELICON POLYPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CHIP; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANTIGEN NY-CO-7,CLL-ASSOCIATED ANTIGEN KW-8,CARBOXY TERMINUS COMPND 5 OF HSP70-INTERACTING PROTEIN,RING-TYPE E3 UBIQUITIN TRANSFERASE CHIP, COMPND 6 STIP1 HOMOLOGY AND U BOX-CONTAINING PROTEIN 1; COMPND 7 EC: 2.3.2.27; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ALL-D HELICON POLYPEPTIDE H203; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STUB1, CHIP, PP1131; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS E3 LIGASE, D-PEPTIDE, STAPLED PEPTIDE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR K.LI,A.J.CALLAHAN,T.L.TRAVALINE,O.S.TOKAREVA,J.-M.SWIECICKI, AUTHOR 2 G.L.VERDINE,B.L.PENTELUTE,J.H.MCGEE REVDAT 3 15-NOV-23 8F16 1 REMARK REVDAT 2 25-OCT-23 8F16 1 REMARK REVDAT 1 15-FEB-23 8F16 0 JRNL AUTH A.J.CALLAHAN,S.GANDHESIRI,T.L.TRAVALINE,L LOZANO SALAZAR, JRNL AUTH 2 S.HANNA,Y.-C.LEE,K.LI,O.S.TOKAREVA,J.-M.SWIECICKI,A.LOAS, JRNL AUTH 3 G.L.VERDINE,J.H.MCGEE,B.L.PENTELUTE JRNL TITL SINGLE-SHOT FLOW SYNTHESIS OF D-PROTEINS FOR MIRROR-IMAGE JRNL TITL 2 PHAGE DISPLAY JRNL REF CHEMRXIV 2023 JRNL REFN ISSN 2573-2293 JRNL DOI 10.26434/CHEMRXIV-2023-X86XP REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 50092 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2436 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.4100 - 4.0100 0.99 3024 149 0.1730 0.1737 REMARK 3 2 4.0100 - 3.1800 0.99 2881 137 0.1700 0.2049 REMARK 3 3 3.1800 - 2.7800 1.00 2846 167 0.1929 0.2085 REMARK 3 4 2.7800 - 2.5300 1.00 2849 144 0.1980 0.2323 REMARK 3 5 2.5300 - 2.3500 1.00 2830 153 0.2001 0.2262 REMARK 3 6 2.3500 - 2.2100 0.95 2680 132 0.2090 0.2546 REMARK 3 7 2.2100 - 2.1000 1.00 2842 120 0.2049 0.2904 REMARK 3 8 2.1000 - 2.0100 1.00 2831 138 0.2086 0.2705 REMARK 3 9 2.0100 - 1.9300 0.99 2796 145 0.2239 0.2642 REMARK 3 10 1.9300 - 1.8600 0.91 2548 121 0.2591 0.3060 REMARK 3 11 1.8600 - 1.8000 1.00 2799 153 0.2211 0.2864 REMARK 3 12 1.8000 - 1.7500 1.00 2774 157 0.2193 0.2726 REMARK 3 13 1.7500 - 1.7100 1.00 2806 136 0.2264 0.2663 REMARK 3 14 1.7100 - 1.6600 1.00 2773 154 0.2413 0.2818 REMARK 3 15 1.6600 - 1.6300 1.00 2794 136 0.2398 0.3007 REMARK 3 16 1.6300 - 1.5900 1.00 2792 140 0.2530 0.3399 REMARK 3 17 1.5900 - 1.5600 1.00 2791 154 0.2605 0.2835 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8F16 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000269797. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08B1-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.18057 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50341 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 45.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.03000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.67600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3Q49 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BICINE PH 8.5, 15% W/V PEG REMARK 280 1,500, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.28000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.64000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.44000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.64000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.28000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.44000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ALL-D HELICON POLYPEPTIDE FP40926 IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 SUBSTRATE ANALOG CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ALL-D HELICON POLYPEPTIDE FP40926 REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 21 REMARK 465 ALA B 22 REMARK 465 ARG B 154 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 41 77.73 -101.81 REMARK 500 LYS A 41 78.52 -107.26 REMARK 500 REMARK 500 REMARK: NULL DBREF 8F16 A 23 154 UNP Q9UNE7 CHIP_HUMAN 23 154 DBREF 8F16 B 23 154 UNP Q9UNE7 CHIP_HUMAN 23 154 DBREF 8F16 C 1 17 PDB 8F16 8F16 1 17 DBREF 8F16 D 1 17 PDB 8F16 8F16 1 17 SEQADV 8F16 GLY A 21 UNP Q9UNE7 EXPRESSION TAG SEQADV 8F16 ALA A 22 UNP Q9UNE7 EXPRESSION TAG SEQADV 8F16 GLY B 21 UNP Q9UNE7 EXPRESSION TAG SEQADV 8F16 ALA B 22 UNP Q9UNE7 EXPRESSION TAG SEQRES 1 A 134 GLY ALA SER PRO SER ALA GLN GLU LEU LYS GLU GLN GLY SEQRES 2 A 134 ASN ARG LEU PHE VAL GLY ARG LYS TYR PRO GLU ALA ALA SEQRES 3 A 134 ALA CYS TYR GLY ARG ALA ILE THR ARG ASN PRO LEU VAL SEQRES 4 A 134 ALA VAL TYR TYR THR ASN ARG ALA LEU CYS TYR LEU LYS SEQRES 5 A 134 MET GLN GLN HIS GLU GLN ALA LEU ALA ASP CYS ARG ARG SEQRES 6 A 134 ALA LEU GLU LEU ASP GLY GLN SER VAL LYS ALA HIS PHE SEQRES 7 A 134 PHE LEU GLY GLN CYS GLN LEU GLU MET GLU SER TYR ASP SEQRES 8 A 134 GLU ALA ILE ALA ASN LEU GLN ARG ALA TYR SER LEU ALA SEQRES 9 A 134 LYS GLU GLN ARG LEU ASN PHE GLY ASP ASP ILE PRO SER SEQRES 10 A 134 ALA LEU ARG ILE ALA LYS LYS LYS ARG TRP ASN SER ILE SEQRES 11 A 134 GLU GLU ARG ARG SEQRES 1 B 134 GLY ALA SER PRO SER ALA GLN GLU LEU LYS GLU GLN GLY SEQRES 2 B 134 ASN ARG LEU PHE VAL GLY ARG LYS TYR PRO GLU ALA ALA SEQRES 3 B 134 ALA CYS TYR GLY ARG ALA ILE THR ARG ASN PRO LEU VAL SEQRES 4 B 134 ALA VAL TYR TYR THR ASN ARG ALA LEU CYS TYR LEU LYS SEQRES 5 B 134 MET GLN GLN HIS GLU GLN ALA LEU ALA ASP CYS ARG ARG SEQRES 6 B 134 ALA LEU GLU LEU ASP GLY GLN SER VAL LYS ALA HIS PHE SEQRES 7 B 134 PHE LEU GLY GLN CYS GLN LEU GLU MET GLU SER TYR ASP SEQRES 8 B 134 GLU ALA ILE ALA ASN LEU GLN ARG ALA TYR SER LEU ALA SEQRES 9 B 134 LYS GLU GLN ARG LEU ASN PHE GLY ASP ASP ILE PRO SER SEQRES 10 B 134 ALA LEU ARG ILE ALA LYS LYS LYS ARG TRP ASN SER ILE SEQRES 11 B 134 GLU GLU ARG ARG SEQRES 1 C 17 ACE DPR DHI DGL MED DCY DTY DTR DAL DAS DAL DTY DCY SEQRES 2 C 17 DAR DTY DSN NH2 SEQRES 1 D 17 ACE DPR DHI DGL MED DCY DTY DTR DAL DAS DAL DTY DCY SEQRES 2 D 17 DAR DTY DSN NH2 HET ACE C 1 3 HET DPR C 2 7 HET DHI C 3 10 HET DGL C 4 9 HET MED C 5 8 HET DCY C 6 6 HET DTY C 7 12 HET DTR C 8 14 HET DAL C 9 5 HET DAS C 10 8 HET DAL C 11 5 HET DTY C 12 12 HET DCY C 13 6 HET DAR C 14 11 HET DTY C 15 12 HET DSN C 16 6 HET NH2 C 17 1 HET ACE D 1 3 HET DPR D 2 7 HET DHI D 3 10 HET DGL D 4 9 HET MED D 5 8 HET DCY D 6 6 HET DTY D 7 12 HET DTR D 8 14 HET DAL D 9 5 HET DAS D 10 8 HET DAL D 11 5 HET DTY D 12 12 HET DCY D 13 6 HET DAR D 14 11 HET DTY D 15 12 HET DSN D 16 6 HET NH2 D 17 1 HET EDO A 201 4 HET EDO A 202 4 HET EDO A 203 4 HET EDO A 204 4 HET EDO A 205 4 HET WHL C 101 14 HET WHL D 101 14 HET EDO D 102 4 HETNAM ACE ACETYL GROUP HETNAM DPR D-PROLINE HETNAM DHI D-HISTIDINE HETNAM DGL D-GLUTAMIC ACID HETNAM MED D-METHIONINE HETNAM DCY D-CYSTEINE HETNAM DTY D-TYROSINE HETNAM DTR D-TRYPTOPHAN HETNAM DAL D-ALANINE HETNAM DAS D-ASPARTIC ACID HETNAM DAR D-ARGININE HETNAM DSN D-SERINE HETNAM NH2 AMINO GROUP HETNAM EDO 1,2-ETHANEDIOL HETNAM WHL N,N'-(1,4-PHENYLENE)DIACETAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 DPR 2(C5 H9 N O2) FORMUL 3 DHI 2(C6 H10 N3 O2 1+) FORMUL 3 DGL 2(C5 H9 N O4) FORMUL 3 MED 2(C5 H11 N O2 S) FORMUL 3 DCY 4(C3 H7 N O2 S) FORMUL 3 DTY 6(C9 H11 N O3) FORMUL 3 DTR 2(C11 H12 N2 O2) FORMUL 3 DAL 4(C3 H7 N O2) FORMUL 3 DAS 2(C4 H7 N O4) FORMUL 3 DAR 2(C6 H15 N4 O2 1+) FORMUL 3 DSN 2(C3 H7 N O3) FORMUL 3 NH2 2(H2 N) FORMUL 5 EDO 6(C2 H6 O2) FORMUL 10 WHL 2(C10 H12 N2 O2) FORMUL 13 HOH *326(H2 O) HELIX 1 AA1 SER A 25 GLY A 39 1 15 HELIX 2 AA2 LYS A 41 ASN A 56 1 16 HELIX 3 AA3 VAL A 59 MET A 73 1 15 HELIX 4 AA4 GLN A 75 ASP A 90 1 16 HELIX 5 AA5 SER A 93 MET A 107 1 15 HELIX 6 AA6 SER A 109 GLN A 127 1 19 HELIX 7 AA7 ASP A 133 GLU A 152 1 20 HELIX 8 AA8 SER B 25 GLY B 39 1 15 HELIX 9 AA9 LYS B 41 ASN B 56 1 16 HELIX 10 AB1 VAL B 59 MET B 73 1 15 HELIX 11 AB2 GLN B 75 ASP B 90 1 16 HELIX 12 AB3 SER B 93 MET B 107 1 15 HELIX 13 AB4 SER B 109 GLN B 127 1 19 HELIX 14 AB5 ASN B 130 GLY B 132 5 3 HELIX 15 AB6 ASP B 133 ARG B 153 1 21 HELIX 16 AB7 DPR C 2 DSN C 16 1 15 HELIX 17 AB8 DPR D 2 DSN D 16 1 15 LINK C ACE C 1 N DPR C 2 1555 1555 1.34 LINK C DPR C 2 N DHI C 3 1555 1555 1.34 LINK C DHI C 3 N DGL C 4 1555 1555 1.33 LINK C DGL C 4 N MED C 5 1555 1555 1.33 LINK C MED C 5 N DCY C 6 1555 1555 1.33 LINK C DCY C 6 N DTY C 7 1555 1555 1.34 LINK SG DCY C 6 CH WHL C 101 1555 1555 1.81 LINK C DTY C 7 N DTR C 8 1555 1555 1.32 LINK C DTR C 8 N DAL C 9 1555 1555 1.34 LINK C DAL C 9 N DAS C 10 1555 1555 1.33 LINK C DAS C 10 N DAL C 11 1555 1555 1.32 LINK C DAL C 11 N DTY C 12 1555 1555 1.32 LINK C DTY C 12 N DCY C 13 1555 1555 1.32 LINK C DCY C 13 N DAR C 14 1555 1555 1.32 LINK SG DCY C 13 CK WHL C 101 1555 1555 1.79 LINK C DAR C 14 N DTY C 15 1555 1555 1.33 LINK C DTY C 15 N DSN C 16 1555 1555 1.33 LINK C DSN C 16 N NH2 C 17 1555 1555 1.33 LINK C ACE D 1 N DPR D 2 1555 1555 1.34 LINK C DPR D 2 N DHI D 3 1555 1555 1.33 LINK C DHI D 3 N DGL D 4 1555 1555 1.32 LINK C DGL D 4 N MED D 5 1555 1555 1.34 LINK C MED D 5 N DCY D 6 1555 1555 1.32 LINK C DCY D 6 N DTY D 7 1555 1555 1.32 LINK SG DCY D 6 CH WHL D 101 1555 1555 1.71 LINK C DTY D 7 N DTR D 8 1555 1555 1.33 LINK C DTR D 8 N DAL D 9 1555 1555 1.33 LINK C DAL D 9 N DAS D 10 1555 1555 1.33 LINK C DAS D 10 N DAL D 11 1555 1555 1.33 LINK C DAL D 11 N DTY D 12 1555 1555 1.33 LINK C DTY D 12 N DCY D 13 1555 1555 1.32 LINK C DCY D 13 N DAR D 14 1555 1555 1.32 LINK SG DCY D 13 CK WHL D 101 1555 1555 1.72 LINK C DAR D 14 N DTY D 15 1555 1555 1.34 LINK C DTY D 15 N DSN D 16 1555 1555 1.33 LINK C DSN D 16 N NH2 D 17 1555 1555 1.33 CRYST1 50.560 66.880 103.280 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019778 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014952 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009682 0.00000